Ob/Gyns are walking away—and it's not just burnout. In this episode of Curie, we investigate the legal, financial, and political forces driving the crisis in women’s health. What happens when an entire specialty starts to disappear?

From ADHD to borderline personality disorder, mental health content is exploding on TikTok—and teens are listening. But is this wave of awareness helping patients, or muddying the waters for clinicians? In this episode of Curie, we explore how social media is changing the way symptoms are understood, identities are formed, and diagnoses are pursued. Featuring insights from clinicians and research on the rising intersection between mental health and the algorithm.

In this post-conference episode, Mike breaks down five major stories from AACR 2025:

• KEYNOTE-689 trial changes the standard of care in head and neck cancer
• Zongertinib delivers HER2-targeted efficacy with fewer side effects in lung cancer
• CAR NK cells show durable remission in AML
• ctDNA testing in CRC detects recurrence 6+ months before imaging
• Werner helicase inhibitor shows first-in-class potential in MSI tumors

Listen in for a concise roundup of the data and why it matters.

Once considered a short-term fix or semi-retirement gig, locum tenens has become a deliberate career choice for tens of thousands of physicians across the U.S.

We discuss:

• What people still misunderstand about locum tenens
• How variety and exposure shape clinical growth
• Why more doctors are walking away from traditional career tracks
• The traits that make someone a great fit for locums—and the traits that don’t
• Whether we’re entering a new chapter in what it means to have a “successful” medical career

Whether you’re considering locum work yourself, or just curious about where physician careers are headed, this is a conversation worth hearing.

A plan to link together massive datasets about autistic Americans has triggered fierce debate. Critics fear it’s a surveillance effort in disguise. Federal agencies say it’s about research. And the autistic community? They're raising serious concerns about privacy, ethics, and unintended consequences. In today’s episode of Curie, Mike unpacks what’s happening inside the Department of Health and Human Services under Secretary Robert F. Kennedy Jr., what’s true, what’s not, and what it could mean for the future of neurodivergent Americans. Love what you hear? Download the Curie app for personalized, in-depth healthcare podcasts curated just for you.

Seventy years ago, Jonas Salk changed history with the first successful polio vaccine—an innovation that reshaped public health and saved millions of lives. But what does his legacy mean in a world now grappling with vaccine skepticism, science politicization, and resurging preventable diseases? In this episode of Curie, we reflect on Salk’s radical generosity, the ethics of scientific discovery, and what today’s healthcare professionals can still learn from his example.

In this Curie episode, Matt previews what’s coming at AACR 2025, happening April 25–30 in Chicago. Get ready for a data-packed week with practice-changing trials like KEYNOTE-689 and Beamion LUNG-1, along with fresh momentum in AI-powered oncology, cancer interception, and new modalities like peptide drug conjugates and RNA-targeting agents. From early detection to trial equity, this preview outlines the trends and themes every oncologist should be watching ahead of the meeting.

A cancer vaccine? It’s not science fiction anymore. In this episode of Curie, host Andrew unpacks a groundbreaking personalized vaccine trial led by Dr. Vinod Balachandran at Memorial Sloan Kettering. By training the immune system to recognize mutations unique to each patient’s tumor, this approach is rewriting the rules of cancer care. We explore how mRNA, long known for its role in COVID vaccines, could become the blueprint for a new era in oncology—one that’s personal, programmable, and potentially transformative.